Global Human Organoids Market 2022-2026

Report
120 Pages
June 2022
Region: Global
TechNavio
ID: 5632883

The publisher has been monitoring the human organoids market and it is poised to grow by $ 1.18 bn during 2022-2026, accelerating at a CAGR of 16.9% during the forecast period. The report on the human organoids market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the advantages of human organoids over traditional methods, the increasing prevalence of human organoids for disease modeling, and the growing prevalence of human organoids for infectious diseases. The human organoids market analysis includes the end-user segment and geographic landscape.

The publisher's human organoids market is segmented as below:

By End-user

Pharmaceutical and biotechnology companies
Contract research organizations
Academic and research institutes
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the mergers and acquisitions, collaborations, and partnerships among vendors as one of the prime reasons driving the human organoids market growth during the next few years. Also, the emergence of bioprinting technology and the growing application of human organoids in medicine personalized development will lead to sizable demand in the market.

The analyst presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The report on the human organoids market covers the following areas:

Human organoids market sizing
Human organoids market forecast
Human organoids market industry analysis .

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human organoids market vendors that include BICO Group AB, BioIVT LLC, Biopredic International, Cellesce Ltd., CN Bio Innovations Ltd., Corning Inc., DefiniGEN Ltd., Emulate Inc., Hubrecht Organoid Technology, InSphero AG, Kirkstall Ltd., Merck KGaA, MIMETAS BV, Miromatrix Medical Inc., Organoid Therapeutics, Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., and ZenBio Inc. Also, the human organoids market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and an analysis of the key vendors.

The analyst presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.uch as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The analyst's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by End-user

5.1 Market segments
Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)
5.2 Comparison by End-user
Exhibit 26: Chart on Comparison by End-user
Exhibit 27: Data Table on Comparison by End-user
5.3 Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026
Exhibit 28: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
5.4 Contract research organizations - Market size and forecast 2021-2026
Exhibit 32: Chart on Contract research organizations - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Contract research organizations - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Contract research organizations - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Contract research organizations - Year-over-year growth 2021-2026 (%)
5.5 Academic and research institutes - Market size and forecast 2021-2026
Exhibit 36: Chart on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Academic and research institutes - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Academic and research institutes - Year-over-year growth 2021-2026 (%)
5.6 Others - Market size and forecast 2021-2026
Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.7 Market opportunity by End-user
Exhibit 44: Market opportunity by End-user ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 48: Chart on Geographic comparison
Exhibit 49: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 Canada - Market size and forecast 2021-2026
Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.11 China - Market size and forecast 2021-2026
Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 86: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 87: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 89: Overview on factors of disruption
9.4 Industry risks
Exhibit 90: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 91: Vendors covered
10.2 Market positioning of vendors
Exhibit 92: Matrix on vendor position and classification
10.3 BioIVT LLC
Exhibit 93: BioIVT LLC - Overview
Exhibit 94: BioIVT LLC - Product / Service
Exhibit 95: BioIVT LLC - Key news
Exhibit 96: BioIVT LLC - Key offerings
10.4 Cellesce Ltd.
Exhibit 97: Cellesce Ltd. - Overview
Exhibit 98: Cellesce Ltd. - Product / Service
Exhibit 99: Cellesce Ltd. - Key offerings
10.5 Corning Inc.
Exhibit 100: Corning Inc. - Overview
Exhibit 101: Corning Inc. - Business segments
Exhibit 102: Corning Inc. - Key offerings
Exhibit 103: Corning Inc. - Segment focus
10.6 DefiniGEN Ltd.
Exhibit 104: DefiniGEN Ltd. - Overview
Exhibit 105: DefiniGEN Ltd. - Product / Service
Exhibit 106: DefiniGEN Ltd. - Key offerings
10.7 Emulate Inc.
Exhibit 107: Emulate Inc. - Overview
Exhibit 108: Emulate Inc. - Product / Service
Exhibit 109: Emulate Inc. - Key offerings
10.8 Hubrecht Organoid Technology
Exhibit 110: Hubrecht Organoid Technology - Overview
Exhibit 111: Hubrecht Organoid Technology - Product / Service
Exhibit 112: Hubrecht Organoid Technology - Key offerings
10.9 Merck KGaA
Exhibit 113: Merck KGaA - Overview
Exhibit 114: Merck KGaA - Business segments
Exhibit 115: Merck KGaA - Key news
Exhibit 116: Merck KGaA - Key offerings
Exhibit 117: Merck KGaA - Segment focus
10.10 Organoid Therapeutics
Exhibit 118: Organoid Therapeutics - Overview
Exhibit 119: Organoid Therapeutics - Product / Service
Exhibit 120: Organoid Therapeutics - Key offerings
10.11 STEMCELL Technologies Inc.
Exhibit 121: STEMCELL Technologies Inc. - Overview
Exhibit 122: STEMCELL Technologies Inc. - Product / Service
Exhibit 123: STEMCELL Technologies Inc. - Key offerings
10.12 ZenBio Inc.
Exhibit 124: ZenBio Inc. - Overview
Exhibit 125: ZenBio Inc. - Product / Service
Exhibit 126: ZenBio Inc. - Key offerings

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 127: Inclusions checklist
Exhibit 128: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 129: Currency conversion rates for US$
11.4 Research methodology
Exhibit 130: Research methodology
Exhibit 131: Validation techniques employed for market sizing
Exhibit 132: Information sources
11.5 List of abbreviations
Exhibit 133: List of abbreviations
investments in R and D by biotechnology firms and federal agencies: Biotechnology companies and research organizations are investing significantly in R and D activities to develop new technologies to improve the quality and standards of their products. They are investing in proteomics, drug testing, high-throughput screening, combinational chemistry, and the development of highly innovative environment-friendly biotechnology reagents. Increased R and D has led to improved healthcare access in the US, countries in Europe, as well as in emerging markets such as China and India, which drives the demand for biotechnology reagents.

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between 2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on End-user - Market share 2021-2026 (%)
Exhibits 25: Data Table on End-user - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by End-user
Exhibits 27: Data Table on Comparison by End-user
Exhibits 28: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Contract research organizations - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Contract research organizations - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Contract research organizations - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Contract research organizations - Year-over-year growth 2021-2026 (%)
Exhibits 36: Chart on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
Exhibits 37: Data Table on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
Exhibits 38: Chart on Academic and research institutes - Year-over-year growth 2021-2026 (%)
Exhibits 39: Data Table on Academic and research institutes - Year-over-year growth 2021-2026 (%)
Exhibits 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits 42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits 44: Market opportunity by End-user ($ million)
Exhibits 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 48: Chart on Geographic comparison
Exhibits 49: Data Table on Geographic comparison
Exhibits 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 82: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits 83: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits 84: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits 85: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits 86: Market opportunity By Geographical Landscape ($ million)
Exhibits 87: Impact of drivers and challenges in 2021 and 2026
Exhibits 88: Overview on Criticality of inputs and Factors of differentiation
Exhibits 89: Overview on factors of disruption
Exhibits 90: Impact of key risks on business
Exhibits 91: Vendors covered
Exhibits 92: Matrix on vendor position and classification
Exhibits 93: BioIVT LLC - Overview
Exhibits 94: BioIVT LLC - Product / Service
Exhibits 95: BioIVT LLC - Key news
Exhibits 96: BioIVT LLC - Key offerings
Exhibits 97: Cellesce Ltd. - Overview
Exhibits 98: Cellesce Ltd. - Product / Service
Exhibits 99: Cellesce Ltd. - Key offerings
Exhibits 100: Corning Inc. - Overview
Exhibits 101: Corning Inc. - Business segments
Exhibits 102: Corning Inc. - Key offerings
Exhibits 103: Corning Inc. - Segment focus
Exhibits 104: DefiniGEN Ltd. - Overview
Exhibits 105: DefiniGEN Ltd. - Product / Service
Exhibits 106: DefiniGEN Ltd. - Key offerings
Exhibits 107: Emulate Inc. - Overview
Exhibits 108: Emulate Inc. - Product / Service
Exhibits 109: Emulate Inc. - Key offerings
Exhibits 110: Hubrecht Organoid Technology - Overview
Exhibits 111: Hubrecht Organoid Technology - Product / Service
Exhibits 112: Hubrecht Organoid Technology - Key offerings
Exhibits 113: Merck KGaA - Overview
Exhibits 114: Merck KGaA - Business segments
Exhibits 115: Merck KGaA - Key news
Exhibits 116: Merck KGaA - Key offerings
Exhibits 117: Merck KGaA - Segment focus
Exhibits 118: Organoid Therapeutics - Overview
Exhibits 119: Organoid Therapeutics - Product / Service
Exhibits 120: Organoid Therapeutics - Key offerings
Exhibits 121: STEMCELL Technologies Inc. - Overview
Exhibits 122: STEMCELL Technologies Inc. - Product / Service
Exhibits 123: STEMCELL Technologies Inc. - Key offerings
Exhibits 124: ZenBio Inc. - Overview
Exhibits 125: ZenBio Inc. - Product / Service
Exhibits 126: ZenBio Inc. - Key offerings
Exhibits 127: Inclusions checklist
Exhibits 128: Exclusions checklist
Exhibits 129: Currency conversion rates for US$
Exhibits 130: Research methodology
Exhibits 131: Validation techniques employed for market sizing
Exhibits 132: Information sources
Exhibits 133: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global human organoids market: BICO Group AB, BioIVT LLC, Biopredic International, Cellesce Ltd., CN Bio Innovations Ltd., Corning Inc., DefiniGEN Ltd., Emulate Inc., Hubrecht Organoid Technology, InSphero AG, Kirkstall Ltd., Merck KGaA, MIMETAS BV, Miromatrix Medical Inc., Organoid Therapeutics, Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., and ZenBio Inc.

Commenting on the report, an analyst from the publishing company said: "The latest trend gaining momentum in the market is mergers and acquisitions, collaborations, and partnerships among vendors."

According to the report, one of the major drivers for this market is the advantages of human organoids over traditional methods.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

BICO Group AB
BioIVT LLC
Biopredic International
Cellesce Ltd.
CN Bio Innovations Ltd.
Corning Inc.
DefiniGEN Ltd.
Emulate Inc.
Hubrecht Organoid Technology
InSphero AG
Kirkstall Ltd.
Merck KGaA
MIMETAS BV
Miromatrix Medical Inc.
Organoid Therapeutics
Organovo Holdings Inc.
Pandorum Technologies Pvt. Ltd.
STEMCELL Technologies Inc.
Thermo Fisher Scientific Inc.
ZenBio Inc.

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2402EUR$2,500USD£2,062GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€4804EUR$5,000USD£4,124GBP

By End-user

By Geographical Landscape

Table of Contents

Executive Summary

Companies Mentioned (Partial List)

Related Topics

Related Reports

Organoids Global Market Report 2024

Organoids Market Size and Forecasts 2020-2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Organ Type, Application, Source, Type, and Geography

Global Human Organoids Market by Product (Colorectal, Heart, Kidney), Usability (Customizable Products, Ready to Use Products), Application, End-Users - Forecast 2024-2030

Organoids Market Forecast to 2028 - Global Analysis By Type, Application, Source, and Geography

Organoids And Spheroids Market Size, Share & Trends Analysis Report By Type (Neurospheres, iPSCs Derived Cells, Hepatic Organoids), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030